Suzanne Ostrand‐Rosenberg
Impact in
- Immunology top 0.02%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Immunology 138
- Immunotherapy and Immune Responses 72
- Immune cells in cancer 62
- Immune Cell Function and Interaction 43
- Immune Response and Inflammation 27
- T-cell and B-cell Immunology 24
- Oncology 63
- Cancer Immunotherapy and Biomarkers 29
- Inflammatory Biomarkers in Disease Prognosis 18
- CAR-T cell therapy research 17
- Co-authors
- Pratima Sinha (32 shared papers)Virginia K. Clements (49 shared papers)Dmitry I. Gabrilovich (5 shared papers)Vincenzo Bronte (3 shared papers)Beth A. Pulaski (6 shared papers)Robert H. Vonderheide (2 shared papers)Stephanie K. Bunt (4 shared papers)Daniel W. Beury (6 shared papers)
- Journals
- The Journal of Immunology (36 papers)Cancer Immunology Immunotherapy (14 papers)Cellular Immunology (11 papers)Cancer Research (10 papers)Journal of Proteome Research (6 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Suzanne Ostrand‐Rosenberg
157 papers receiving 24.6k citations
Suzanne Ostrand‐Rosenberg's Hit Papers
Peers
Comparison fields: 5 of 139
- Immunology 17.0k
- Oncology 9.7k
- Cancer Research 2.1k
- Biological Psychiatry 301
- Neurology 715
Countries citing papers authored by Suzanne Ostrand‐Rosenberg
This map shows the geographic impact of Suzanne Ostrand‐Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Ostrand‐Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Ostrand‐Rosenberg more than expected).
Fields of papers citing papers by Suzanne Ostrand‐Rosenberg
This network shows the impact of papers produced by Suzanne Ostrand‐Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Ostrand‐Rosenberg. The network helps show where Suzanne Ostrand‐Rosenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne Ostrand‐Rosenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Understanding the tumor immune microenvironment (TIME) for effective therapy Hit paper breakdown → | 2018 | 4151 |
| 2 | Coordinated regulation of myeloid cells by tumours Hit paper breakdown → | 2012 | 2837 |
| 3 | Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards Hit paper breakdown → | 2016 | 2054 |
| 4 | Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer Hit paper breakdown → | 2009 | 1398 |
| 5 | Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine Hit paper breakdown → | 2009 | 775 |
| 6 | Mouse 4T1 Breast Tumor Model Hit paper breakdown → | 2000 | 749 |
| 7 | Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response Hit paper breakdown → | 2007 | 684 |
| 8 | Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells Hit paper breakdown → | 2007 | 604 |
| 9 | Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells Hit paper breakdown → | 2008 | 573 |
| 10 | Reduced Inflammation in the Tumor Microenvironment Delays the Accumulation of Myeloid-Derived Suppressor Cells and Limits Tumor Progression Hit paper breakdown → | 2007 | 522 |
| 11 | 2012 | 476 | |
| 12 | 2006 | 448 | |
| 13 | 2010 | 424 | |
| 14 | 2015 | 421 | |
| 15 | 2018 | 400 | |
| 16 | 2008 | 360 | |
| 17 | 2005 | 359 | |
| 18 | 2009 | 341 | |
| 19 | 2004 | 269 | |
| 20 | 2012 | 262 |
About Suzanne Ostrand‐Rosenberg
Suzanne Ostrand‐Rosenberg is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 157 papers that have together received 24.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (72 papers), Immune cells in cancer (62 papers), Immune Cell Function and Interaction (43 papers), Cancer Immunotherapy and Biomarkers (29 papers), Immune Response and Inflammation (27 papers), T-cell and B-cell Immunology (24 papers), Inflammatory Biomarkers in Disease Prognosis (18 papers) and CAR-T cell therapy research (17 papers). The work is most often cited by research in Immunology (17.0k citations), Oncology (9.7k citations), Cancer Research (2.1k citations), Biological Psychiatry (301 citations) and Neurology (715 citations). Suzanne Ostrand‐Rosenberg has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Pratima Sinha, Virginia K. Clements, Dmitry I. Gabrilovich, Vincenzo Bronte, Beth A. Pulaski, Robert H. Vonderheide, Stephanie K. Bunt, Daniel W. Beury, Paulo C. Rodrı́guez and Catherine Fenselau. Their work appears in journals such as The Journal of Immunology, Cancer Immunology Immunotherapy, Cellular Immunology, Cancer Research and Journal of Proteome Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.